• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—May 21

    Iterative Scopes Expands its Senior Leadership Team

    Viz.ai Raises $100 Million in Series D Funding

    FDA Clears Arterys' AI Mapping and Quantification Tools

    Prometheus Group Sued Over Reused Catheters and Rectal Sensors
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Concise Engineering

    BMP Medical

    Cirtec Medical

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Concise Engineering

    BMP Medical

    Cirtec Medical

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Healthcare, Breakthrough Technology, and the 2020 Election: A Summer Update

    With only a year and two months until the 2020 presidential election, Washington is buckled down and ready for yet another busy season of campaigning.

    Healthcare, Breakthrough Technology, and the 2020 Election: A Summer Update
    Related CONTENT
    • An Update on the 2020 Presidential Election and Recent Regulatory Changes
    • The FDA Wants to Bring Manufacturing ‘Home’
    • RenovaCare Receives FDA Conditional IDE Approval of CellMist System and SkinGun Device
    • FDA OKs SentiAR's Holographic Cardiac Ablation Guidance System
    • GE Healthcare Unveils Voluson SWIFT AI-Enhanced Women’s Health Ultrasound
    Jeffrey J. Kimbell, David C. Rudloff and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc.09.06.19
    With only a year and two months until the 2020 presidential election, Washington is buckled down and ready for yet another busy season of campaigning and partisan politics. While President Trump is almost certainly going to be the Republican nominee, over 20 Democrats are currently vying to be their party’s standard bearer in the presidential election. The timeline is shorter for these candidates, as the first Democratic primary—the Iowa Caucuses—are only five months away. With the rising cost of healthcare on the mind of many voters, Democratic candidates are eager to differentiate themselves and formulate policy positions to stick out from the herd. However, while those policies may make catchy hashtags in the near-term, some could fundamentally change the nation’s healthcare system and pose significant challenges for the life science industry.

    Meanwhile, in the Executive Branch, the Trump Administration has been busy putting out regulatory proposals that will potentially increase patient access to innovative medical technology if finalized. It is unclear, however, if this will be enough to sway public support in favor of Trump’s healthcare ideas.

    2020 Election Update: Healthcare
    Three of the four frontrunners in the Democratic Presidential primary—Former Vice President Joe Biden, U.S. Sen. Bernie Sanders (I-VT), and U.S. Sen. Kamala Harris (D-CA)—have developed extensive healthcare reform proposals as part of their campaign platforms. A fourth frontrunner—U.S. Sen. Elizabeth Warren (D-MA)—has yet to formally introduce a healthcare proposal, but has strongly associated herself with Sanders’ calls for Medicare for All. The following is a summary of where each candidate stands on major healthcare reform ideas.

    Joe Biden: The former vice president is attempting to solidify his role as the frontrunner in a large Democratic primary field. With a significant advantage in name recognition, Biden is currently leading the polls with 32 percent, according to RealClearPolitics polling averages. In his campaign, Biden has struck a moderate left-of-center tone, running on his electability and a continuation of the policies of President Barack Obama. Biden’s 2020 healthcare proposal calls for preserving popular aspects of the Affordable Care Act (ACA), including Medicaid expansion and protections for individuals with preexisting conditions, while establishing a new government-run public insurance option. The plan authorizes Medicare to negotiate drug prices directly with manufacturers, allows for the importation of prescription drugs from foreign countries, and provides tax credits to allow consumers to buy health insurance. According to the Biden campaign, the proposal will cost $750 billion over a decade and be paid for by raising individual and corporate income taxes. It remains to be seen whether Biden can maintain his frontrunner status as the Democratic base moves further to the left and amplifies calls to radically transform America’s healthcare system from the ground up.

    Bernie Sanders: Vermont’s independent senator is championing his trademark Medicare for All proposal, which would radically transform the U.S. healthcare system by creating a universal, single-payer health program that would replace most current forms of health insurance and provide comprehensive healthcare benefits at no cost to patients. The cost estimate of this program to the federal government is estimated at roughly $28-32 trillion over a decade. Sanders’ plan would be paid for by enormous increases in payroll taxes, income taxes, income-based premiums taxes, estate taxes, and the creation of a “wealth tax” on the super-rich, defined as the top 0.1 percent of the wealth scale. The slogan of Medicare for All, which makes for a catchy bumper-sticker, enjoys public support in many surveys, but when respondents are informed that the policy would eliminate private health insurance, the concept becomes especially unpopular. While some on the left are eager to push for Medicare for All, other more moderate members of the Democratic Caucus see it as a risk for Trump’s re-election and favor a more incremental approach. Sanders is currently second to Biden in the Democratic primary polls, earning fervent support from the more progressive left base of the party; however, polling at around 16 percent, some are starting to question whether he’s reached his ceiling of support.

    Kamala Harris: With her campaign’s healthcare proposal, Harris is attempting to bridge the divide between Biden’s public option and Sanders’s single-payer plan. Harris’ plan, which she also referred to as Medicare for All, would build both a public option and retain Medicare Advantage alongside private insurance. Under the plan, Americans would be able to buy into Medicare and private insurers would be allowed to offer Medicare plans subject to government regulations to lower costs and expand services through a 10-year transition period. To pay for her plan, Harris would implement a 0.2 percent tax on Wall Street stock trades, 0.1 percent tax on bond trades, 0.0002 percent tax on derivative transactions, and offshore corporate incomes would be taxed equally to domestic corporate income. Harris’ proposal has received criticism from both Biden, who accused the senator of misleading voters since the plan would take away private health insurance in 10 years, and Sanders, who claimed that Harris’ plan is a handout to private insurance companies. Harris is currently polling in fourth place in the Democratic primary at around 10-12 percent. Right now, it appears that her campaign strategy is an attempt to stake out the middle ground between the progressive and more moderate wings of the party. Utilizing this strategy, however, risks being labelled a “flip-flopper,” as shown during the first Democratic primary debate when Harris initially expressed support for abolishing private health insurance, but later clarified that private insurance would still exist for supplemental coverage under her healthcare plan.

    Elizabeth Warren: Third-place polling  Warren has yet to formally introduce a healthcare platform, instead putting her full support behind Sanders’ single-payer Medicare for All proposal. As an original co-sponsor of Sanders’ bill (S. 1129), the Medicare for All Act, Warren has mostly echoed the Vermont senator on the issue, stating “I’m with Bernie” when asked at the first Democratic primary debate and continuing to disparage for-profit healthcare in general. In the past, Warren has also supported legislation to grant the government authority to manufacture certain generic drugs. Right now, it appears that Warren believes tying herself to Sanders as they chase a similar group of further left progressive voters will prove effective. Warren still has plenty of time to develop a more targeted healthcare platform as the field narrows, and she will eventually have to differentiate herself from Sanders, having told reporters as late as May that she is considering multiple approaches to expanding coverage.

    While Democratic presidential contenders vie to be their party’s standard bearer in the 2020 presidential election and flirt with the idea of single-payer healthcare, President Trump and other Administration officials have taken the opportunity to voice opposition to the concept, claiming government-run healthcare would bring disaster and major disruption to America’s healthcare system. Single-payer Medicare for All would create a one-size-fits-all health system that eliminates the free market, and Republicans in Washington believe it would force patients, physicians, and hospitals to operate at the margins of an anti-competitive federal bureaucracy. A public option, while being touted as a less radical proposal than Medicare for All, would represent a step toward single payer. Private insurers generally reimburse hospitals and other providers at much higher rates than Medicare, so an increase in Medicare enrollment would put enormous financial pressure on providers, affecting patient choice and access to care.

    Reimbursement Update for Breakthrough Devices
    In our June update, we discussed the U.S. Food and Drug Administration’s (FDA) Breakthrough Devices Program, which was created in 2016 under the 21st Century Cures Act to provide expedited assessment and review of products deemed to be new and innovative breakthrough technologies. For a medical device to earn a breakthrough designation, it must: (1) provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases; (2) have no approved alternatives; (3) offer significant advantages over existing approved alternatives; or (4) have its availability be in the best interest of patients.

    On July 29, the Centers for Medicare and Medicaid Services (CMS) released the Calendar Year 2020 Outpatient Prospective Payment System (OPPS) Proposed Rule, which provides updated payment rates and policy changes for the OPPS and Ambulatory Surgical Center Payment System under Medicare Part B. Related to breakthrough devices, CMS is proposing to alter how the agency makes determinations for transitional pass-through payments—a payment system created by Congress intended to foster innovative medical devices, drugs, and biologicals, where such products must satisfy certain criteria related to newness, cost, and substantial clinical improvement. Specifically, CMS is proposing an alternative pathway to the substantial clinical improvement criterion that would fast-track transformative new devices. For applications received on or after Jan. 1, 2020, CMS is proposing an innovative medical device that is part of the FDA’s Breakthrough Devices Program and has received FDA-marketing authorization would not be evaluated under—and would be automatically considered to have met—the current substantial clinical improvement criterion. The pass-through applicant would still need to meet the established eligibility, device categories, and cost criteria.

    This proposal is consistent with another recently finalized policy we discussed in our June update included in the Fiscal Year 2020 Inpatient Prospective Payment System Proposed Rule, where CMS will now automatically grant New Technology Add-on Payment (NTAP) status—the Medicare Part A analog to transitional pass-through payments—to medical devices with breakthrough distinction from FDA, provided they meet the applicable cost threshold for NTAP.

    Additionally, on July 30, the Office of Management and Budget (OMB) within the White House began reviewing a potential proposed rule from CMS titled, “Medicare Coverage of Innovative Medical Technologies.” According to a previously released description from this spring, this proposed rule would modify the Medicare coverage process to streamline coverage of breakthrough technologies that have the potential to improve patient health outcomes and quality of care. If and when OMB clears this proposal in its regulatory review, CMS will then formally release the proposed rule and seek public comment on it. 


    Jeffrey J. Kimbell, president and founder of Jeffrey J. Kimbell & Associates Inc., represents 35 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the firm provides strategic solutions to hand-selected clients seeking creation, modification, or proper implementation of public law.

    David C. Rudloff is a manager of government relations at Jeffrey J. Kimbell & Associates Inc.

    Caroline P. Tucker is a manager of health policy and reimbursement strategy at Jeffrey J. Kimbell & Associates Inc. 
    Related Searches
    • tax
    • 21st century cures act
    • trademark
    • breakthrough
    Suggested For You
    An Update on the 2020 Presidential Election and Recent Regulatory Changes An Update on the 2020 Presidential Election and Recent Regulatory Changes
    The FDA Wants to Bring Manufacturing ‘Home’ The FDA Wants to Bring Manufacturing ‘Home’
    RenovaCare Receives FDA Conditional IDE Approval of CellMist System and SkinGun Device RenovaCare Receives FDA Conditional IDE Approval of CellMist System and SkinGun Device
    FDA OKs SentiAR FDA OKs SentiAR's Holographic Cardiac Ablation Guidance System
    GE Healthcare Unveils Voluson SWIFT AI-Enhanced Women’s Health Ultrasound GE Healthcare Unveils Voluson SWIFT AI-Enhanced Women’s Health Ultrasound
    FDA OKs Masimo’s Rad-G Pulse Oximeter FDA OKs Masimo’s Rad-G Pulse Oximeter
    FDA Clears Scientia Vascular FDA Clears Scientia Vascular's Zoom Wire
    Let’s Build This: Best Practices for Utilizing External Regulatory Expertise Let’s Build This: Best Practices for Utilizing External Regulatory Expertise
    GE Healthcare, Osprey Medical Forge Distribution Alliance GE Healthcare, Osprey Medical Forge Distribution Alliance
    FDA Authorizes First Point-of-Care COVID-19 Antibody Test FDA Authorizes First Point-of-Care COVID-19 Antibody Test
    FDA OKs Surmodics FDA OKs Surmodics' Pounce Thrombus Retrieval System
    FDA Launches the Digital Health Center of Excellence FDA Launches the Digital Health Center of Excellence
    Acutus AcQMap Catheter Cleared by FDA Acutus AcQMap Catheter Cleared by FDA
    FDA OKs Varian FDA OKs Varian's Eclipse v16.1 Proton Therapy Treatment Planning Software
    FDA Approves Expanded Use of Roche FDA Approves Expanded Use of Roche's CINtec PLUS Cytology Test

    Related Content

    • An Update on the 2020 Presidential Election and Recent Regulatory Changes

      An Update on the 2020 Presidential Election and Recent Regulatory Changes

      The 2020 presidential election is heating up as both parties held their national conventions in late August.
      Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 10.01.20

    • Contract Manufacturing
      The FDA Wants to Bring Manufacturing ‘Home’

      The FDA Wants to Bring Manufacturing ‘Home’

      The agency commissioners comment how the need to modernize the critical medical supply chain is long overdue.
      Sean Fenske, Editor-in-Chief 10.01.20

    • RenovaCare Receives FDA Conditional IDE Approval of CellMist System and SkinGun Device

      RenovaCare Receives FDA Conditional IDE Approval of CellMist System and SkinGun Device

      The approval will enable the company to initiate a clinical study of the products for safety and feasibility.
      Globe Newswire 09.30.20


    • Cardiovascular | Surgical
      FDA OKs SentiAR

      FDA OKs SentiAR's Holographic Cardiac Ablation Guidance System

      Allows electrophysiologists to visualize 3D electroanatomic models in real-time, via a wearable headset.
      PR Newswire 09.30.20

    • Patient Monitoring
      GE Healthcare Unveils Voluson SWIFT AI-Enhanced Women’s Health Ultrasound

      GE Healthcare Unveils Voluson SWIFT AI-Enhanced Women’s Health Ultrasound

      Industry-first auto recognition tools help improve efficiency.
      GE Healthcare 09.30.20


      Trending
      • 5 Ways Plastics Revolutionized The Healthcare Industry | Medical Product Outsourcing
      • The Future Of Biomedical Engineering Advancements | Medical Product Outsourcing
      • Accelerating Product Development In The Age Of Digital Innovation | Medical Product Outsourcing
      • Viz.ai Raises $100 Million In Series D Funding | Medical Product Outsourcing
      • Medical Device Trends To Watch For In 2022 And Beyond | Medical Product Outsourcing
      Breaking News
      • MPO's Most-Read Stories This Week—May 21
      • Iterative Scopes Expands its Senior Leadership Team
      • Viz.ai Raises $100 Million in Series D Funding
      • FDA Clears Arterys' AI Mapping and Quantification Tools
      • Prometheus Group Sued Over Reused Catheters and Rectal Sensors
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      What Are You Reading?
      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—May 21
      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      P&G Closes HQ Due To Security Threat, Launches New Hair Care Line
      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Zeller+Gmelin, Sun Chemical and Kornit Top This Week’s News
      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Brook + Whittle's new acquisition, SunDance goes to HP and more
      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Kimberly-Clark to Expand Diaper, Wipes Production in Brazil; The Honest Company to Sell Diapers, Wipes at Walmart & More
      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most Read Stories This Week—May 21
      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Graphene Flagship, Japan Display and LG Display Top This Week’s Stories
      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login